Josh T. Pearson

847 total citations
23 papers, 633 citations indexed

About

Josh T. Pearson is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Josh T. Pearson has authored 23 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Josh T. Pearson's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Protein purification and stability (5 papers). Josh T. Pearson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Protein purification and stability (5 papers). Josh T. Pearson collaborates with scholars based in United States. Josh T. Pearson's co-authors include Dan A. Rock, Larry C. Wienkers, R. Foti, Jan L. Wahlstrom, Brooke M. Rock, Mei Han, William M. Atkins, John A. Davis, John J. Hill and Kevin D. Cook and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Biochemistry.

In The Last Decade

Josh T. Pearson

22 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josh T. Pearson United States 16 205 204 176 137 98 23 633
Hugues Dolgos Germany 16 208 1.0× 392 1.9× 227 1.3× 45 0.3× 25 0.3× 26 792
Michael Lisurek Germany 19 550 2.7× 288 1.4× 119 0.7× 73 0.5× 40 0.4× 28 854
Michio Tsutsui Japan 8 456 2.2× 402 2.0× 221 1.3× 23 0.2× 84 0.9× 8 901
Soraya Madani United States 6 86 0.4× 291 1.4× 153 0.9× 67 0.5× 32 0.3× 8 534
Masashi Hyuga Japan 17 519 2.5× 154 0.8× 57 0.3× 99 0.7× 43 0.4× 48 950
Malkeet Singh Bahia India 15 343 1.7× 42 0.2× 99 0.6× 78 0.6× 34 0.3× 35 901
Sumiko Hyuga Japan 17 564 2.8× 156 0.8× 102 0.6× 80 0.6× 44 0.4× 54 982
Rubén Alvarez‐Sánchez Switzerland 15 294 1.4× 61 0.3× 104 0.6× 31 0.2× 46 0.5× 24 728
Steven Hansel United States 14 200 1.0× 28 0.1× 166 0.9× 53 0.4× 123 1.3× 29 683
Jennie Walgren United States 9 301 1.5× 186 0.9× 83 0.5× 85 0.6× 11 0.1× 14 593

Countries citing papers authored by Josh T. Pearson

Since Specialization
Citations

This map shows the geographic impact of Josh T. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh T. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh T. Pearson more than expected).

Fields of papers citing papers by Josh T. Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josh T. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh T. Pearson. The network helps show where Josh T. Pearson may publish in the future.

Co-authorship network of co-authors of Josh T. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of Josh T. Pearson. A scholar is included among the top collaborators of Josh T. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josh T. Pearson. Josh T. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sckisel, Gail D., Anupama Sahoo, Almin Lalani, et al.. (2020). Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity. Frontiers in Immunology. 11. 832–832. 55 indexed citations
2.
Khoryati, Liliane, Minh N. Pham, Kevin D. Cook, et al.. (2020). An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice. Science Immunology. 5(50). 91 indexed citations
3.
Han, Mei, Josh T. Pearson, Yunan Wang, et al.. (2017). Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo. Analytical Biochemistry. 539. 118–126. 21 indexed citations
4.
Han, Mei, Brooke M. Rock, Josh T. Pearson, & Dan A. Rock. (2015). Intact mass analysis of monoclonal antibodies by capillary electrophoresis—Mass spectrometry. Journal of Chromatography B. 1011. 24–32. 57 indexed citations
5.
Pearson, Josh T. & Dan A. Rock. (2015). Bioanalytical Approaches to Assess The Proteolytic Stability of Therapeutic Fusion Proteins. Bioanalysis. 7(23). 3035–3051. 12 indexed citations
6.
Pearson, Josh T.. (2014). Imagining Alternatives. Science Fiction Studies. 41(2). 464–464.
7.
Pearson, Josh T., et al.. (2013). An extended range generic immunoassay for total human therapeutic antibodies in preclinical pharmacokinetic studies. Journal of Immunological Methods. 393(1-2). 70–73. 11 indexed citations
8.
Foti, R., Josh T. Pearson, Julie Zalikowski, et al.. (2012). Predicting the Drug Interaction Potential of AMG 853, a Dual Antagonist of the D-Prostanoid and Chemoattractant Receptor-Homologous Molecule Expressed on T Helper 2 Cells Receptors. Drug Metabolism and Disposition. 40(12). 2239–2249. 2 indexed citations
9.
Davis, John A., Dan A. Rock, Larry C. Wienkers, & Josh T. Pearson. (2012). In Vitro Characterization of the Drug-Drug Interaction Potential of Catabolites of Antibody-Maytansinoid Conjugates. Drug Metabolism and Disposition. 40(10). 1927–1934. 25 indexed citations
10.
VandenBrink, Brooke M., John A. Davis, Josh T. Pearson, et al.. (2012). Cytochrome P450 Architecture and Cysteine Nucleophile Placement Impact Raloxifene-Mediated Mechanism-Based Inactivation. Molecular Pharmacology. 82(5). 835–842. 19 indexed citations
11.
Foti, R., Dan A. Rock, Josh T. Pearson, Jan L. Wahlstrom, & Larry C. Wienkers. (2011). Mechanism-Based Inactivation of Cytochrome P450 3A4 by Mibefradil through Heme Destruction. Drug Metabolism and Disposition. 39(7). 1188–1195. 34 indexed citations
12.
Pearson, Josh T., et al.. (2010). The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4. Archives of Biochemistry and Biophysics. 497(1-2). 68–81. 23 indexed citations
13.
Foti, R., Josh T. Pearson, Dan A. Rock, Jan L. Wahlstrom, & Larry C. Wienkers. (2009). In Vitro Inhibition of Multiple Cytochrome P450 Isoforms by Xanthone Derivatives from Mangosteen Extract. Drug Metabolism and Disposition. 37(9). 1848–1855. 34 indexed citations
14.
Foti, R., Leslie J. Dickmann, John A. Davis, et al.. (2008). Metabolism and related human risk factors for hepatic damage by usnic acid containing nutritional supplements. Xenobiotica. 38(3). 264–280. 45 indexed citations
15.
Rock, Dan A., R. Foti, & Josh T. Pearson. (2008). The Combination of Chemical and Antibody Inhibitors for Superior P450 3A Inhibition in Reaction Phenotyping Studies. Drug Metabolism and Disposition. 36(12). 2410–2413. 2 indexed citations
16.
Pearson, Josh T., Jan L. Wahlstrom, Leslie J. Dickmann, et al.. (2007). Differential Time-Dependent Inactivation of P450 3A4 and P450 3A5 by Raloxifene: A Key Role for C239 in Quenching Reactive Intermediates. Chemical Research in Toxicology. 20(12). 1778–1786. 42 indexed citations
17.
Pearson, Josh T., et al.. (2006). Surface Plasmon Resonance Analysis of Antifungal Azoles Binding to CYP3A4 with Kinetic Resolution of Multiple Binding Orientations. Biochemistry. 45(20). 6341–6353. 55 indexed citations
18.
Roberts, Arthur G., Dolores Díaz, Jed N. Lampe, et al.. (2006). NMR Studies of Ligand Binding to P450eryF Provides Insight into the Mechanism of Cooperativity. Biochemistry. 45(6). 1673–1684. 23 indexed citations
19.
Pearson, Josh T., et al.. (2005). The central loop of Escherichia coli glutamine synthetase is flexible and functionally passive. Archives of Biochemistry and Biophysics. 436(2). 397–405. 8 indexed citations
20.
Mehta, Ranjana, Josh T. Pearson, Sumit Mahajan, et al.. (2004). Adenylylation and Catalytic Properties of Mycobacterium tuberculosis Glutamine Synthetase Expressed in Escherichia coli versus Mycobacteria. Journal of Biological Chemistry. 279(21). 22477–22482. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugues Dolgos Breakdown of academic impact, for papers by Michael Lisurek Breakdown of academic impact, for papers by Michio Tsutsui Breakdown of academic impact, for papers by Soraya Madani Breakdown of academic impact, for papers by Masashi Hyuga Breakdown of academic impact, for papers by Malkeet Singh Bahia Breakdown of academic impact, for papers by Sumiko Hyuga Breakdown of academic impact, for papers by Rubén Alvarez‐Sánchez Breakdown of academic impact, for papers by Steven Hansel Breakdown of academic impact, for papers by Jennie Walgren
Rankless by CCL
2026